These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Value of immunosuppressive agents in corneal diseases]. Fallas P; Castier P; Langlois M; Lenski C; Woillez M Bull Soc Ophtalmol Fr; 1984 Oct; 84(10):1171-4. PubMed ID: 6544177 [No Abstract] [Full Text] [Related]
6. [Some remarks on the treatment of marginal corneal ulcers (author's transl)]. Arkin W Klin Oczna; 1981 Feb; 83(2):109-10. PubMed ID: 6167756 [No Abstract] [Full Text] [Related]
7. Use of intravenous cyclophosphamide in the prevention of corneal melt: justified or not? Clewes AR; Tunn EJ; Kaye S; Bucknall RC Rheumatology (Oxford); 2005 Feb; 44(2):257-8. PubMed ID: 15637047 [No Abstract] [Full Text] [Related]
8. Expression of matrix metalloproteinases 2 and 9 in experimental corneal injury and fungal keratitis. Mitchell BM; Wu TG; Chong EM; Pate JC; Wilhelmus KR Cornea; 2007 Jun; 26(5):589-93. PubMed ID: 17525657 [TBL] [Abstract][Full Text] [Related]
9. [Orthokeratology induced infective corneal ulcer]. Lü L; Zou L; Wang R Zhonghua Yan Ke Za Zhi; 2001 Nov; 37(6):443-6. PubMed ID: 11840754 [TBL] [Abstract][Full Text] [Related]
10. Traditional eye medicines and corneal ulceration in Tanzania. Yorston D; Foster A J Trop Med Hyg; 1994 Aug; 97(4):211-4. PubMed ID: 8064942 [TBL] [Abstract][Full Text] [Related]
11. Use of intravenous cyclophosphamide in the prevention of corneal melt: justified or not? Liu DT; Chan AY Rheumatology (Oxford); 2006 Jul; 45(7):920; author reply 921-2. PubMed ID: 16581815 [No Abstract] [Full Text] [Related]
12. Marginal ulceration of the cornea. Br Med J; 1971 Feb; 1(5744):303-4. PubMed ID: 4925227 [No Abstract] [Full Text] [Related]
13. Classifying the severity of corneal ulcers by using the "1, 2, 3" rule. Vital MC; Belloso M; Prager TC; Lanier JD Cornea; 2007 Jan; 26(1):16-20. PubMed ID: 17198008 [TBL] [Abstract][Full Text] [Related]
14. How useful are scrapings in the treatment of corneal ulcers? Van Slycken S; Zeyen T Bull Soc Belge Ophtalmol; 1993; 249():117-23. PubMed ID: 7952340 [TBL] [Abstract][Full Text] [Related]
15. [Use of amorphous ribonuclease in the treatment of suppurative corneal ulcers]. Batmanov IuE; Novikova GF Vestn Oftalmol; 1972; 3():17-8. PubMed ID: 5049972 [No Abstract] [Full Text] [Related]
16. Clinical trial of povidone-iodine (Betadine) versus placebo in the pretreatment of corneal ulcers. Gregori NZ; Schiffman JC; Miller DM; Alfonso EC Cornea; 2006 Jun; 25(5):558-63. PubMed ID: 16783144 [TBL] [Abstract][Full Text] [Related]
17. Clinical application of nerve growth factor on human corneal ulcer. Lambiase A; Manni L; Rama P; Bonini S Arch Ital Biol; 2003 Mar; 141(2-3):141-8. PubMed ID: 12825325 [TBL] [Abstract][Full Text] [Related]
18. Dianabol in corneal ulcers. Prasad VN; Gupta HC; Shukla CN J All India Ophthalmol Soc; 1969 Feb; 17(1):31-2. PubMed ID: 5371050 [No Abstract] [Full Text] [Related]
19. [Special aspects of marginal corneal ulcers in Africa]. Diallo J; Turcat JP; Moliva G; Bassabi S Bull Soc Med Afr Noire Lang Fr; 1971; 16(1):68-72. PubMed ID: 5566647 [No Abstract] [Full Text] [Related]